Mindmaze Therapeutics HoldinMMTZF

13F holders, Q3 2024 (September 30)
2holders +1
1new positions
0sold out
$2.99avg. 13F price*

At the end of Q3 2024, 2 institutions reported holding Mindmaze Therapeutics Holdin (MMTZF) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Horizon Financial Services, LLC ($230) and Strategic Investment Solutions, Inc. ($36).

Company
Mindmaze Therapeutics Holdin
Filed as
RELIEF THERAPEUTIC ORDF (Q3 2024)
CUSIP
H6759S118
Latest filing quarter
Q2 2026

History

Number of 13F holders

012 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 2Q3 2024Q4 2024: 2Q4 2024Q1 2025: 2Q1 2025Q2 2025: 2Q2 2025Q3 2025: 2Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions1$36
Exits0$0

All 13F filers, Q2 2024 → Q3 2024: 12 shares bought, net +12 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Horizon Financial Services, LLC 0.00% No change 77 $230
Strategic Investment Solutions, Inc. 0.00% New 12 $36

"% of holder's portfolio" is MMTZF's weight in each manager's 13F, not the share of Mindmaze Therapeutics Holdin the manager owns.